We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Orion Group Holdings
ORN
$514M
| $822K | 0.02% |
110,066
-800
| -0.7% | -$5.98K |
|
|
RFP
602
DELISTED
Resolute Forest Products Inc.
RFP
| $815K | 0.02% |
185,211
+31,500
| +20% | +$156K |
|
603
Standard BioTools
LAB
$326M
| $813K | 0.02% |
201,251
+24,700
| +14% | +$117K |
|
604
Portland General Electric
POR
$6.02B
| $812K | 0.02% |
17,780
+2,030
| +13% | +$93.6K |
|
605
Titan Machinery
TITN
$466M
| $811K | 0.02% |
45,090
+13,478
| +43% | +$221K |
|
|
TNAV
606
DELISTED
Telenav Inc.
TNAV
| $808K | 0.02% |
99,749
+35,700
| +56% | +$303K |
|
607
Preferred Bank
PFBC
$1.22B
| $807K | 0.02% |
15,090
+1,690
| +13% | +$87.1K |
|
608
Asbury Automotive
ABG
$4.19B
| $796K | 0.02% |
14,070
+9,320
| +196% | +$536K |
|
|
TRST
609
Trustco Bank Corp NY
TRST
$1B
| $793K | 0.02% |
20,460
| – | – |
|
610
Sempra
SRE
$60.8B
| $772K | 0.02% |
+13,700
| New | +$775K |
|
|
BGG
611
DELISTED
Briggs & Stratton Corp.
BGG
| $766K | 0.02% |
+31,800
| New | +$753K |
|
612
DHI Group
DHX
$166M
| $763K | 0.02% |
267,680
+102,840
| +62% | +$339K |
|
|
MIK
613
DELISTED
Michaels Stores, Inc
MIK
| $759K | 0.02% |
41,000
-230,200
| -85% | -$4.79M |
|
|
TESO
614
DELISTED
Tesco Corp
TESO
| $757K | 0.02% |
+170,125
| New | +$938K |
|
|
TTPH
615
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $754K | 0.02% |
5,285
-365
| -6% | -$56.4K |
|
616
Oracle
ORCL
$331B
| $745K | 0.02% |
14,850
-156,570
| -91% | -$7.14M |
|
|
SP
617
DELISTED
SP Plus Corporation
SP
| $739K | 0.02% |
+24,185
| New | +$752K |
|
618
Unum
UNM
$13.8B
| $733K | 0.02% |
+15,720
| New | +$723K |
|
|
TBHC
619
DELISTED
The Brand House Collective
TBHC
| $730K | 0.02% |
71,024
+50,830
| +252% | +$543K |
|
|
ARAV
620
DELISTED
Aravive, Inc. Common Stock
ARAV
| $727K | 0.02% |
6,946
+4,446
| +178% | +$478K |
|
|
PRSU
621
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $723K | 0.02% |
15,298
-13,142
| -46% | -$588K |
|
|
EXTN
622
DELISTED
Exterran Corporation
EXTN
| $721K | 0.02% |
+26,990
| New | +$766K |
|
623
Nu Skin
NUS
$247M
| $716K | 0.02% |
11,400
-58,970
| -84% | -$3.36M |
|
624
RenaissanceRe
RNR
$13.8B
| $715K | 0.02% |
+5,140
| New | +$722K |
|
625
Exelixis
EXEL
$13.9B
| $712K | 0.02% |
+28,910
| New | +$612K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.